GSK Pharma names Carson Dalton as Executive Vice President, Communications and Government Affairs
Advertisement
Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, Communications and Government Affairs effective 3rd March 2025.
Ransom Dsouza will be retiring from this position effective 31st May 2025.
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability. Prior to joining GSK, he served as Senior Director at Coca-Cola India and Southwest Asia, where he delivered strong outcomes for the Public Affairs, Communications and Sustainability function for the operating unit.
Before joining Coca-Cola, Carson was the founding head of the Ola Mobility Institute (OMI), a corporate think-tank that is focused on new age Mobility like Electric Vehicles. He also spearheaded market access for Ola's ride hailing services.
Prior to this, Carson was Facebook's first head of communications in India and played a pivotal role in the long-term growth of WhatsApp and Instagram across the Indian sub-continent. Carson's experience spans the Telecom sector having earlier worked with British Telecom (BT) in India, London, and Singapore and Idea Cellular where he started the Public Relation s function. Carson began his career as a journalist for leading publications like the Indian Express, MidDay and JAM Magazine.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.